Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

The American Society for Radiation Oncology will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO's 55th Annual Meeting, September 22-25, 2013, in Atlanta.

24 Sep 2013

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Depression in cancer patients who receive RT can be identified by 2-item questionnaire

Cancer patients receiving radiotherapy (RT) who are potentially suffering from depression can be effectively identified by a two-item questionnaire, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Proton radiotherapy proves to be cost-effective in treating pediatric brain tumors

Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Protecting stem cells around hippocampus in brain reduces rate of memory loss in cancer patients

Protecting the stem cells that reside in and around the hippocampus - a C-shaped area in the temporal lobe on both sides of the brain associated with the ability to form and store memories - substantially reduces the rate of cancer patients' memory loss during whole-brain radiotherapy without a significant risk of recurrence in that area of the brain, a new study shows.

24 Sep 2013

Two-question screening test may reveal depression in cancer patients

Cancer patients can be accurately screened for major depression with a simple two-question survey, according to a study presented Sept. 23 at the American Society for Radiation Oncology's 55th Annual Meeting.

24 Sep 2013

Swallow therapy combats post-radiotherapy dysphagia

Swallowing exercises can help to minimize the risk for dysphagia in patients undergoing radiotherapy for head and neck cancer, a case study suggests.

20 Sep 2013

CHMP recommends approval of Xofigo for CRPC, symptomatic bone and visceral metastases

Bayer HealthCare announced today that the the European Committee for Medicinal Products for Human Use recommended Xofigo (radium Ra 223 dichloride) for approval with a proposed indication for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.

20 Sep 2013

UH Seidman Cancer Center to become one of elite group of cancer centers to offer proton therapy

University Hospitals Seidman Cancer Center is breaking ground today on a $30 million proton therapy center, becoming one of an elite group of cancer centers in the country to offer this revolutionary technology. There are currently only 11 operational proton therapy centers in the nation and the UH Seidman Cancer Center site will be the first in Ohio.

20 Sep 2013

Shorter course of radiotherapy safe and effective for women with breast cancer

The long-term results of the landmark START trials conclusively confirm that giving radiotherapy as a lower overall dose in fewer, higher doses over a shorter treatment time (hypofractionated) is at least as effective and safe as the current international standard for most women with early breast cancer.

19 Sep 2013

Radiotherapy combined with breast-conserving surgery reduces risk of local recurrence in women DCIS

Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS).

19 Sep 2013

Affimed Therapeutics, LLS partner to co-fund AFM13 phase 2 trial for treatment of Hodgkin Lymphoma

Affimed Therapeutics AG and The Leukemia & Lymphoma Society today announced a partnership to co-fund a phase 2 trial with the Recruit-TandAb AFM13, a novel tetravalent bispecific antibody directed against human CD30 and CD16A in Hodgkin Lymphoma patients for whom currently available treatments have failed.

16 Sep 2013

New study to reduce unwanted side-effects of radiotherapy

Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.

From The University of Manchester 12 Sep 2013

Exposing young girls to ionizing radiation can raise risk of breast cancer later in life

Exposing young women and girls under the age of 20 to ionizing radiation can substantially raise the risk of their developing breast cancer later in life. Scientists may now know why. A collaborative study, in which Berkeley Lab researchers played a pivotal role, points to increased stem cell self-renewal and subsequent mammary stem cell enrichment as the culprits.

12 Sep 2013

Breast Cancer Symposium highlights risk and use of radiotherapy, MRI in DCIS patients

New studies exploring breast cancer risk perceptions and use of radiotherapy and MRI for women with ductal carcinoma in situ (DCIS, a preinvasive form of breast cancer) were highlighted today in a virtual presscast in advance of the 2013 Breast Cancer Symposium.

7 Sep 2013

Prophylactic cranial irradiation beneficial in elderly SCLC patients

Prophylactic cranial irradiation improves survival in elderly patients with limited-stage small-cell lung cancer, analysis of US epidemiologic data indicates.

6 Sep 2013

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment.

5 Sep 2013

Certain Hodgkin lymphoma treatments put patients at increased risk for stomach cancer

Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health.

28 Aug 2013

Virttu Biologics treats first cohort of patients in SEPREHVIR Phase I/IIa study

Virttu Biologics Limited, a UK biotechnology company with expertise in the field of oncolytic viruses, has announced that it has treated the first cohort of patients in its Phase I/IIa clinical study of its oncolytic virus, SEPREHVIR (HSV1716) for the treatment of malignant pleural mesothelioma.

27 Aug 2013

Seven researchers to receive grants from ASTRO to advance radiation oncology research

The American Society for Radiation Oncology (ASTRO) has selected seven (7) leading researchers who will receive a total of $675,000 in awards and grants to advance radiation oncology research.

23 Aug 2013

Radiotherapy News and Research

Further Reading

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Depression in cancer patients who receive RT can be identified by 2-item questionnaire

Proton radiotherapy proves to be cost-effective in treating pediatric brain tumors

Protecting stem cells around hippocampus in brain reduces rate of memory loss in cancer patients

Two-question screening test may reveal depression in cancer patients

Swallow therapy combats post-radiotherapy dysphagia

CHMP recommends approval of Xofigo for CRPC, symptomatic bone and visceral metastases

UH Seidman Cancer Center to become one of elite group of cancer centers to offer proton therapy

Shorter course of radiotherapy safe and effective for women with breast cancer

Radiotherapy combined with breast-conserving surgery reduces risk of local recurrence in women DCIS

Affimed Therapeutics, LLS partner to co-fund AFM13 phase 2 trial for treatment of Hodgkin Lymphoma

New study to reduce unwanted side-effects of radiotherapy

Exposing young girls to ionizing radiation can raise risk of breast cancer later in life

Breast Cancer Symposium highlights risk and use of radiotherapy, MRI in DCIS patients

Prophylactic cranial irradiation beneficial in elderly SCLC patients

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

Certain Hodgkin lymphoma treatments put patients at increased risk for stomach cancer

Virttu Biologics treats first cohort of patients in SEPREHVIR Phase I/IIa study

Seven researchers to receive grants from ASTRO to advance radiation oncology research

Cancer Research - Second Edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News